日本生研甲乙型流感快檢試劑盒

廣州健侖生物科技有限公司

廣州健侖長期供應各種流感檢測試劑，包括進口和國產的品牌，主要包括日本富士瑞必歐、日本生研、美國BD、美國NovaBios、美國binaxNOW、凱必利、廣州創侖等主流品牌。

日本生研甲乙型流感快檢試劑盒

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

歡迎咨詢

歡迎咨詢2042552662

想了解更多的產品及服務請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室

“隨著其它基因變化一起，失活的Pax5驅動正常血細胞變成白血病細胞，之前已經報道過，”劉女士說。“然而我們*揭示重新復活Pax5能夠使細胞重新開始其正常發育并丟失那些類似癌癥的特性，有效地治療白血病。吸引我們的是只是回復Pax5就足夠使這些癌細胞恢復常態化，盡管其它基因是改變的。”
白血病中，未成熟白血細胞復制異常并在骨髓中累積，干擾正常血細胞的產生。
劉女士說在兒童B-ALL中Pax5常常是一個‘消失’的基因。“Pax5對于一種白血細胞——b細胞正常發育*的，”她說。“當Pax5功能缺乏抵抗力時，發育中的B細胞陷入一種不成熟狀態并且變成癌性的。我們證明恢復Pax5功能，即使是在已經發生癌病的細胞中，移除這個‘阻塞’，使得細胞發育成正常白血細胞。”
Dickins博士說這項研究揭示了Pax5的功能，是約100種已知‘抑制’人類腫瘤的基因之一。“當這些腫瘤抑制基因通過改變DNA而被失活時，腫瘤開始發育，”Dickins博士說。
“這項工作揭示如何鈍化腫瘤抑制基因Pax5促成B-ALL 發育以及白血病細胞如何變成‘熱愛’低Pax5水平以繼續激增。縱使B-ALL 細胞有多種基因突變，只是簡單的復活Pax5引起腫瘤細胞恢復正常發育并失去它們的癌變性質。”

"As other genetic changes, inactivated Pax5 drives normal blood cells to become leukemic cells, as previously reported," Ms. Liu said. "However, for the first time, we have shown that resuscitation of Pax5 allows cells to restart their normal development and lose those cancers-like properties that effectively treat leukemias, and it is enough to appeal to Pax5 that these cells are restored to normalization, although other genes are changed."
In leukemia, immature white blood cells replicate abnormally and accumulate in the bone marrow, interfering with the production of normal blood cells.
Ms. Liu said Pax5 is often a 'vanishing' gene in children with B-ALL. "Pax5 is essential for the normal development of a white blood cell-b cell," she said. "When Pax5 function lacks resistance, developing B cells plunge into an immature state and become cancerous.We show that restoring Pax5 function, even in cells where cancer has already occurred, removes this 'obstruction' , Making the cells develop into normal white blood cells. "
Dr. Dickins said the study revealed the function of Pax5 and is one of about 100 genes known to 'suppress' human tumors. "Tumors begin to develop when these tumor suppressor genes are inactivated by changing DNA," says Dr. Dickins.
"This work revealed how to passivate the tumor suppressor gene Pax5 to promote B-ALL development and how leukemic cells turn into 'loving' low Pax5 levels to continue the surge even though B-ALL cells have multiple genetic mutations that simply cause Pax5 to resuscitate Tumor cells resume normal development and lose their cancerous properties. "